Guest blog post by Dr. Panteli Theocharous, Global Vice President, Cell and Gene Therapy Strategic Lead, Thermo Fisher Scientific Decades of work and new understanding transformed cell and gene therapies (CGTs) from a hyped-up possibility to a life-changing reality for many patients. CGTs represent a growing market in the United States and other regions of the world, with multiple new global approvals expected within the next few years. However, patient challenges and operating model complexities threaten realization of the CGT promise and require innovators and partners to find…